Open Session to mark ITB\u2019s 67th Dies Natalis was held at ITB\u2019s\nGanesha Campus on Monday, 2 March, with a focus on strengthening\nresearch and innovation for national self-reliance. The anniversary\nserved as a moment of reflection and a reaffirmation of ITB\u2019s commitment\nas a leading, impactful university.<\/p>\n
In his address, Budi Gunadi Sadikin, Chair of ITB\u2019s Board of Trustees\n(MWA ITB), stressed the importance of adaptive and accountable\ngovernance to meet global challenges. He noted that ITB plays a\nstrategic role in strengthening the national innovation ecosystem\nthrough synergy among the campus, government, and industry, ensuring\nresearch outputs connect with industrial needs and public policy.<\/p>\n
\u201cSynergy between academics, government, and industry is considered\nthe key to driving the downstreaming of research with competitive\nstrength,\u201d he said.<\/p>\n
Chairman of the Academic Senate (AS) ITB, Edy Tri Baskoro, asserted\nthat institutional transformation must remain grounded in academic\nquality. Academic freedom, scientific integrity and high quality\nstandards form the foundation for upholding ITB\u2019s heritage while\nensuring the intellectual contributions are relevant to national\ndevelopment.<\/p>\n
Meanwhile, ITB Rector Tatacipta Dirgantara, in his address outlined\nITB\u2019s strategic direction toward achieving a World University Ranking of\n150 by 2030. The achievement rests on the quality of the academic staff\nand the strengthening of the substance of the tridharma\u2014the three\npillars of higher education\u2014in line with the vision \u201cITB Berdampak\u201d (ITB\nwith Impact).<\/p>\n
\u201cThrough interdisciplinary collaboration, strengthened governance,\nand expansion of international networks, ITB is directed to continue\ndelivering solutions to national challenges in the fields of industry,\nenergy, and health,\u201d he said.<\/p>\n
SCIENTIFIC ORATION<\/p>\n
On that occasion, ITB\u2019s Director of Research and Innovation, and also\na Professor in the Biopharmacology Expertise Group of the ITB School of\nPharmacy (SF), Elfahmi, delivered his scientific oration on the topic\n\u201cDownstreaming and Commercialisation of Indonesia\u2019s Natural\nMaterials-based Research and Innovation for Health Autonomy\u201d.<\/p>\n
Elfahmi highlighted Indonesia\u2019s biodiversity potential as a source of\ndrug materials and health products based on natural materials. \u201cHowever,\nthis potential must be optimised through downstream processing that is\nstructured, starting from basic research, safety and efficacy testing,\nto the development of market-ready products,\u201d he said.<\/p>\n
Elfahmi stressed that research should not stop at publication or\npatents. The research results must be translated into products that can\nbe produced, utilised, and directly benefit the people. \u201cTherefore,\nclose collaboration between the campus, industry, government, and\nregulators is essential,\u201d he stated.<\/p>\n
According to Elfahmi, health self-sufficiency is part of national\nsovereignty. By strengthening research and production based on domestic\nnatural resources, Indonesia has a great opportunity to reduce import\ndependence while becoming a leading player in the health industry based\non natural materials. (E-2)<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/open-session-for-itbs-67th-dies-natalis-strengthening-impactful-research-and-the-downstream-processing-of-1772557804", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }